Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
selective estrogen receptor modulator |
| gptkbp:CASNumber |
68047-06-3
|
| gptkbp:chemicalFormula |
C26H29NO2
|
| gptkbp:drugClass |
antineoplastic agent
antiestrogen |
| gptkbp:hasInChIKey |
NKANXQFJJICGDU-QPLCGJKRSA-N
|
| gptkbp:hasSMILES |
CN(C)CCOc1ccc(cc1)/C(=C(/c2ccccc2)c3ccccc3)/O
|
| https://www.w3.org/2000/01/rdf-schema#label |
4-hydroxytamoxifen
|
| gptkbp:is_active_metabolite_of |
gptkb:tamoxifen
|
| gptkbp:IUPACName |
(Z)-2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
|
| gptkbp:meltingPoint |
138-140°C
|
| gptkbp:metabolism |
gptkb:tamoxifen
|
| gptkbp:molecularWeight |
387.51 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL123
62742 |
| gptkbp:target |
estrogen receptor alpha
estrogen receptor beta |
| gptkbp:UNII |
1A6N6GBZ4U
|
| gptkbp:used_in |
gptkb:Cre-ERT2_recombinase_systems
breast cancer research |
| gptkbp:bfsParent |
gptkb:tamoxifen
|
| gptkbp:bfsLayer |
6
|